IC13 Flashcards

1
Q

Generic name for LIORESAL

A

baclofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Intrathecal administration of LIORESAL cause Baclofen conc in CSF to be ____ times higher compared to oral administration

A

100 times

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Because of slow CSF circulation and a baclofen concentration gradient from the___ to the____ CSF, the PK parameters should be interpreted considering a___

A

lumbar; cisternal; high inter- and intra-patient variability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is intrathecal baclofen cleared?

A

via bulk-flow removal of CSF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LIORESAL: Direct infusion into the spinal subarachnoid space bypasses absorption processes and allows exposure to the _____.

A

receptor sites in the dorsal horn of the spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LIORESAL: indication

A
  • Management of severe spasticity due to spinal cord injury or multiple sclerosis who are unresponsive to oral baclofen or who experience unacceptable side effects at effective oral doses.
  • alternative to destructive neurosurgical procedures.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LIORESAL: can it be administered via parenteral routes e.g. IV,IM other than intrathecal?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What device is used to administer LIORESAL?

A

implantable pump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LIORESAL: adverse effects

A

life-threatening CNS depression, cardiovascular collapse and/or respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What can be observed at the tip of implanted catheter with LIORESAL* Intrathecal? What are the consequences?

A

Inflammatory mass; decreased therapeutic response, pain and serious neurological impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Early symptoms of baclofen withdrawal may include ____

A

return of baseline spasticity, pruritus, hypotension, and paresthesias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Advanced LIORESAL* Intrathecal withdrawal syndrome may resemble _____

A

autonomic dysreflexia, infection (sepsis), malignant hyperthermia, neuroleptic-malignant syndrome, or other conditions associated with a hypermetabolic state or widespread rhabdomyolysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Caution use of LIORESAL* Intrathecal in patients with renal impairment because baclofen is _____.

A

primarily excreted unchanged through the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LIORESAL: storage

A

Protect from heat (store at 15-30°C). Do not freeze. Do not heat sterilize.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

LIORESAL: Each ampoule is intended for___ use only.

A

single

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

If LIORESAL is to be diluted, what diuent to use?

A

sterile preservative-free sodium chloride injection (under aseptic condition)

17
Q

Can dextrose be mixed with LIORESAL?

A

No, incompatible

18
Q

Can LIORESAL be mixed with other infusion or injection solutions?

19
Q

LIORESAL: very common side effects

A

Drowsiness, muscle weakness

20
Q

PRIALT: Generic name

A

ziconotide

21
Q

MOA for PRIALT

A

Blocks N-type calcium channel located on the primary nociceptive (A-δ and C) afferent nerves in the superficial layers (Rexed laminae I and II) of the dorsal horn in the spinal cord

22
Q

Indication for PRIALT

A

management of severe chronic pain (if pt is intolerant or refractory to other tx)

23
Q

Can PRIALT be administered IV?

24
Q

PRIALT: Saline solutions containing___ are NOT appropriate for intrathecal drug administration and should not be used due to risk of _____.

A

preservatives; neurotoxicity

25
Special administration instruction for PRIALT
Refrigerate but do not freeze all PRIALT solutions after preparation and begin infusion within 24 hours.
26
What kind of molecule is ziconotide?
peptide
27
Is ziconotide expected to have CYP interactions?
No, ziconotide is a peptide, it is expected to be completely degraded by endopeptidases and exopeptidases (Phase I hydrolytic enzymes)
28
Is ziconotide highly ptn bound?
No, not highly bound in plasma (approximately 50%) and has low plasma exposure following intrathecal administration
29
Device used for ziconotide administration
an appropriate microinfusion device *Medtronic SynchroMed® II Infusion System or CADD-Micro Ambulatory Infusion Pump.
30
PRIALT: storage
* Refrigerate PRIALT during transit. * Store PRIALT at 2°C to 8°C (36°F to 46°F). * PRIALT, once diluted aseptically with saline, may be stored at 2°C to 8°C for 24 hours. * Do NOT freeze PRIALT. * Protect from light.
31
Intradermal delivers drug into the ___
epidermis
32
Examples of efflux tpt at BBB
BCRP, PGP, MDRP